l carnitine c reactive protein Deficiency in Chronic Kidney Disease: Pathophysiology, Clinical Implications, and Therapeutic Perspectives Role of L-carnitine in Cardiovascular

Atalay Guzel N, Erikoglu Orer G, Bircan FS, Cokun Cevher

This product is not intended to diagnose, treat, cure, or prevent any disease

Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications: part 2

5 The organization is careful to note that except in the case of evidence of subclinical disease defining the presence of ASCVD, reclassification to a higher risk category is a matter of clinical judgment. 5 The guidelines reference the JUPITER trial, as described above, in their consideration of additional cardiovascular risk factors, but do not provide further evaluation of the evidence